Director and Head of Corporate and Strategic Development, Tessara Therapeutics Pty Ltd
| Role | Organisation | Sources |
|---|---|---|
| Director | Tessara Therapeutics Pty Ltd | Wholesale Investor |
| Director and Head of Corporate and Strategic Development | Tessara Therapeutics Pty Ltd | Wholesale Investor |
Stories naming Christopher Boyer. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Tessara Therapeutics closed a $2.7 million oversubscribed Round 1 raise led by a New South Wales syndicate, appointed Phillip Smith to its board, and works with CSIRO and Bio-Link Australia.
Wholesale Investor profile of Tessara Therapeutics, a biotech developing 3D human brain tissue for drug discovery; recounts past grants, an R&D tax incentive, CSIRO partnership, board and revenue projections.